Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2Sylwia Ammoun, C. Oliver Hanemann|Neuro-Oncology|2011Cited by 54
Human Endogenous Retrovirus Type K Promotes Proliferation and Confers Sensitivity to Antiretroviral Drugs in Merlin-Negative Schwannoma and MeningiomaEmmanuel A. Maze, Sylwia Ammoun|Cancer Research|2021Cited by 25